MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ CAPITAL |
Anteile |
2.4 M |
Marktkapitalisierung |
$ 100 K |
EBITDA (LTM) |
$ -11.9 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
-4.12 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
DBV Technologies S.A.
DBVT
|
$ 9.75 | 0.72 % | $ 1.36 B | Nasdaq Global Select Market |  France |
 |
Alterity Therapeutics Limited
ATHE
|
$ 2.09 | -2.79 % | $ 13.4 B | Nasdaq Capital Market |  Australia |
 |
Shineco, Inc.
TYHT
|
- | -3.90 % | $ 97.2 M | Nasdaq Global Select Market |  China |
 |
Actinium Pharmaceuticals
ATNM
|
$ 1.52 | -2.56 % | $ 47.4 M | NYSE American | USA |
 |
Millendo Therapeutics, Inc.
MLND
|
- | -5.36 % | $ 20.2 M | Nasdaq Global Select Market | USA |
 |
DiaMedica Therapeutics
DMAC
|
$ 8.72 | 1.04 % | $ 410 M | Nasdaq Capital Market | USA |
 |
Aytu BioScience
AYTU
|
$ 1.9 | -4.04 % | $ 23.4 M | Nasdaq Capital Market | USA |
 |
Dyadic International
DYAI
|
$ 0.4 | -0.75 % | $ 14.5 M | Nasdaq Capital Market | USA |
 |
Intec Pharma Ltd
NTEC
|
- | -12.45 % | $ 17.7 M | Nasdaq Capital Market |  Israel |
 |
Edesa Biotech
EDSA
|
$ 2.77 | 0.36 % | $ 15.7 M | Nasdaq Capital Market | USA |
 |
Progenity, Inc.
PROG
|
- | -3.47 % | $ 164 M | Nasdaq Global Select Market | USA |
 |
Lantern Pharma
LTRN
|
$ 0.64 | -0.83 % | $ 6.97 M | Nasdaq Global Select Market | USA |
 |
Strongbridge Biopharma plc
SBBP
|
- | 1.52 % | $ 136 M | Nasdaq Global Select Market | USA |
 |
Fennec Pharmaceuticals
FENC
|
$ 10.08 | -2.33 % | $ 288 M | Nasdaq Capital Market | USA |
 |
Seneca Biopharma, Inc.
SNCA
|
- | -1.19 % | $ 28.7 M | Nasdaq Capital Market | USA |
 |
Cardiff Oncology
CRDF
|
$ 0.91 | -2.23 % | $ 60.8 M | Nasdaq Capital Market | USA |
 |
Inhibrx
INBX
|
$ 93.38 | -3.83 % | $ 4.4 B | Nasdaq Global Select Market | USA |
 |
Eton Pharmaceuticals
ETON
|
$ 50.0 | -0.04 % | $ 1.35 B | Nasdaq Global Market | USA |
 |
ImmuCell Corporation
ICCC
|
$ 10.25 | -1.82 % | $ 92.5 M | Nasdaq Global Select Market | USA |
 |
Fulcrum Therapeutics
FULC
|
$ 3.68 | -0.14 % | $ 233 M | Nasdaq Global Market | USA |
 |
Kamada Ltd.
KMDA
|
$ 7.77 | 0.52 % | $ 448 M | Nasdaq Global Select Market | Israel |
 |
IDEAYA Biosciences
IDYA
|
$ 34.71 | -3.9 % | $ 3.07 B | Nasdaq Global Select Market | USA |
 |
InflaRx N.V.
IFRX
|
$ 1.56 | 1.96 % | $ 105 M | Nasdaq Global Select Market |  Germany |
 |
Immutep Limited
IMMP
|
$ 3.2 | 1.91 % | $ 4.66 B | Nasdaq Global Market | Australia |
 |
Mustang Bio
MBIO
|
$ 0.37 | 0.22 % | $ 1.82 M | Nasdaq Global Market | USA |
 |
Kala Pharmaceuticals
KALA
|
$ 0.19 | 2.48 % | $ 1.55 M | Nasdaq Global Select Market | USA |
 |
Mereo BioPharma Group plc
MREO
|
$ 0.28 | -1.98 % | $ 223 M | Nasdaq Global Select Market |  Britain |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
$ 76.73 | -5.03 % | $ 5.69 B | Nasdaq Global Select Market | USA |
 |
Karyopharm Therapeutics
KPTI
|
$ 0.52 | -5.24 % | $ 5.69 K | Nasdaq Global Select Market | USA |
 |
Seres Therapeutics
MCRB
|
$ 2.09 | -1.88 % | $ 18.5 M | Nasdaq Global Select Market | USA |
 |
MediWound Ltd.
MDWD
|
$ 12.0 | -1.48 % | $ 327 M | Nasdaq Global Select Market | Israel |
 |
Precigen
PGEN
|
$ 6.19 | -3.13 % | $ 1.94 B | Nasdaq Global Select Market | USA |
 |
PolyPid Ltd.
PYPD
|
$ 5.25 | 2.34 % | $ 85.8 M | Nasdaq Global Select Market | Israel |
 |
Rocket Pharmaceuticals
RCKT
|
$ 2.29 | -0.87 % | $ 254 M | Nasdaq Global Select Market | USA |
 |
Avidity Biosciences
RNA
|
$ 8.2 | 0.49 % | $ 1.13 B | Nasdaq Global Select Market | USA |
 |
Summit Therapeutics
SMMT
|
$ 15.47 | -0.51 % | $ 11.6 B | Nasdaq Global Select Market | Britain |
 |
Celsion Corporation
CLSN
|
- | -6.63 % | $ 13.9 M | Nasdaq Capital Market | USA |
 |
Генетико
GECO
|
- | - | - | MOEX |  Russia |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market | France |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market | France |
 |
Scholar Rock Holding Corporation
SRRK
|
$ 41.49 | -1.12 % | $ 4.76 B | Nasdaq Global Select Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | Germany |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
- | 0.74 % | $ 768 M | Nasdaq Capital Market | Israel |
 |
Abcam plc
ABCM
|
- | - | $ 4.9 B | Nasdaq Global Select Market | Britain |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market | Britain |
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market | Germany |
 |
Affimed N.V.
AFMD
|
- | -34.95 % | $ 21.5 M | Nasdaq Global Select Market,SPB | Germany |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
- | -1.58 % | $ 28.1 M | Nasdaq Global Market | China |